C. Cuadra

Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors

R. Salazar, J. Tabernero, L. Paz-Ares, 2013, Cancer Chemotherapy and Pharmacology.

A phase I and pharmacokinetic study of elisidepsin (PM02734) in patients with advanced solid tumors

R. Salazar, A. Soto-Matos, A. Oaknin, 2012, Cancer Chemotherapy and Pharmacology.

A phase I clinical and pharmacokinetic study (LIPOTEC - GP PHARM/DOXO 01) of a new liposomal doxorubicin given as 3-week schedule in patients with solid tumors

R. Salazar, M. Majem, B. Pardo, 2009, Journal of liposome research.

Complete and Sustained Objective Response per RECIST to Irvalec (PM02734) in Undifferentiated Large Cell Esophageal Adenocarcinoma: A Case Report and a Review of the Literature

R. Salazar, V. Alfaro, M. Gil-Martin, 2012, Case Reports in Oncology.

Phase I and pharmacokinetic study of trabectedin 3-hour infusion every three weeks in patients with advanced cancer and alteration of hepatic function

R. Salazar, L. Paz-Ares, C. Lebedinsky, 2012, Medical Oncology.

A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients.

R. Salazar, R. Alemany, M. Cascalló, 2019, Human gene therapy.

A phase I trial of oncolytic adenovirus ICOVIR-5 administered intravenously to melanoma patients.

R. Salazar, R. Alemany, M. Cascalló, 2018, Human gene therapy. Clinical development.